Literature DB >> 9407366

Physicians' guide to interactions between glaucoma and systemic medications.

M S Gottfredsdottir1, R R Allingham, M B Shields.   

Abstract

PURPOSE: To develop a Physicians' Guide to assist clinicians in the concomitant use of glaucoma and systemic medications.
METHODS: The records of 100 consecutive patients with chronic open-angle glaucoma were retrospectively studied to determine the most common systemic medications that are prescribed in this population. The ten most common drug classes were then used to construct a guide to potential interactions and side effects when these medications are used concomitantly with glaucoma drugs.
RESULTS: Eighty-four patients were receiving 1 or more medications (a mean of 3.5) for a mean of 2.6 systemic conditions. Systemic antihypertensive agents was the most common class of drugs, being used by 48 patients. Aspirin, the most common single systemic drug, was being used by 25 patients.
CONCLUSIONS: A high percentage of patients with chronic open-angle glaucoma receive a wide variety of medications for coexisting systemic disorders. The concomitant use of glaucoma and systemic medications creates the potential for drug interactions, as well as side effects for both groups of drugs, for which the Physicians' Guide may be beneficial.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407366

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  7 in total

1.  Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.

Authors:  Kazuyuki Hirooka; Fumio Shiraga
Journal:  Clin Ophthalmol       Date:  2007-09

2.  Prevalence of diabetes mellitus and hypertension among Indian glaucoma patients and evaluation of systemic therapy.

Authors:  Abhishek Dave; Shveta Jindal Bali; Reetika Sharma; Aruj K Khurana; Raghav Gupta; Tanuj Dada
Journal:  Int Ophthalmol       Date:  2013-02-14       Impact factor: 2.031

3.  Ophthalmic drugs as part of polypharmacy in nursing home residents with glaucoma.

Authors:  Matthias Huber; Marita Kölzsch; Ralf Stahlmann; Werner Hofmann; Juliane Bolbrinker; Dagmar Dräger; Reinhold Kreutz
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

4.  Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma.

Authors:  E Nitta; K Hirooka; K Tenkumo; T Fujita; A Nishiyama; T Nakamura; T Itano; F Shiraga
Journal:  Cell Death Dis       Date:  2013-07-04       Impact factor: 8.469

5.  Effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma.

Authors:  Mehdi Siddiqui; Joshua Iltis; Petar Yanev; John Sladic; Charles Huynh; Daniel Nolan; Michael Singer
Journal:  Clin Ophthalmol       Date:  2019-01-23

6.  Acute ocular hypertension disrupts barrier integrity and pump function in rat corneal endothelial cells.

Authors:  Xian Li; Zhenhao Zhang; Lijun Ye; Jufeng Meng; Zhongyang Zhao; Zuguo Liu; Jiaoyue Hu
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

Review 7.  Glaucoma history and risk factors.

Authors:  Charles W McMonnies
Journal:  J Optom       Date:  2016-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.